New Publication: Medical Device Industry in India

Posted by By at 4 May, at 16 : 09 PM Print

Medical Device Industry in India

Regulatory, Legal and Tax Issues

May 04, 2023


India is counted among the top 20 global medical devices market and is presently valued at USD 11 billion and is expected to reach USD 65 billion by 2024. The Indian medical device market is dominated by imported products, which comprise of around 80% of total sales.

The Indian medical device market offers a great opportunity not only in terms of its size, but also because of encouraging policies and regulations that the Government has introduced to give a fillip to the medical device industry. For instance, in March 2020, the government approved ‘Production-Linked Incentives (PLI) Scheme for Medical Devices. Earlier in 2019, the government undertook to set up four medical devices parks in Andhra Pradesh, Telangana, Tamil Nadu and Kerala. The medical device parks are expected to reduce manufacturing costs, as these will be equipped with the necessary infrastructure. In addition to PLIs, as of 2023, the Government is also considering offering Research Linked Incentives (RLIs) for indigenous research and production.

The regulatory landscape for medical devices in India has undergone a colossal revamp in 2020 and the Government is still in the process of implementing the same. In this paper we have outlined the legal and regulatory landscape India and the India-specific considerations global medical device companies should keep in mind. In addition, we also discuss entry strategies, intellectual property considerations and the tax regime that affects the medical device industry in India.


Varsha RajeshEshika PhadkeDarren Punnen and Dr.Milind Antani

We hope you find this paper useful.

Please click here to access our paper.

For any help or assistance, please email us on

Do visit us at


Chambers and Partners Asia Pacific 2023: Top Tier for Tax, TMT, Employment, Life Sciences, Dispute Resolution, FinTech Legal

Legal 500 Asia Pacific 2023: Top Tier for Tax, TMT, Labour & Employment, Life Sciences & Healthcare, Dispute Resolution

Benchmark Litigation Asia Pacific 2022: Top Tier for Tax, Labour & Employment, International Arbitration

IFLR1000 2022: Top Tier for M&A and Private Equity

AsiaLaw Asia-Pacific 2022: Top Tier for Tax, TMT, Investment Funds, Private Equity, Labour and Employment, Dispute Resolution

FT Innovative Lawyers Asia Pacific 2019 Awards: NDA ranked 2nd in the Most Innovative Law Firm category (Asia-Pacific Headquartered)

RSG-Financial Times: India’s Most Innovative Law Firm 2019, 2017, 2016, 2015, 2014


The contents of this Publication should not be construed as legal opinion. View detailed disclaimer.

This Publication provides general information existing at the time of preparation. The Publication is intended as a news update and Nishith Desai Associates neither assumes nor accepts any responsibility for any loss arising to any person acting or refraining from acting as a result of any material contained in this Publication. It is recommended that professional advice be taken based on the specific facts and circumstances. This Publication does not substitute the need to refer to the original pronouncements.
This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender’s contact information, which this mail does. In case this mail doesn’t concern you, please unsubscribe from mailing list.


Related Posts

Post Your Comment

You must be logged in to post a comment.

About Us

Nishith Desai Associates (NDA) is a research based international law firm with offices in Mumbai, Bangalore, Silicon Valley, Singapore, New Delhi, Munich and New York.


Mobile App